Impact of tofogliflozin on hepatic outcomes: a systematic review

ConclusionOverall, an improvement in levels of hepatic parameters was observed in T2DM patients with concurrent liver disorders. However, a large number of clinical trials are needed to prove the efficacy of tofogliflozin on hepatic outcomes in patients with T2DM.

http://link.springer.com/10.1007/s00228-023-03537-w

Source: European Journal of Clinical Pharmacology - July 18, 2023 Category: Drugs & Pharmacology Source Type: research